Comments on: FDA rejects AstraZeneca and FibroGen’s roxadustat NDA for CKD related anemia

Comments on: FDA rejects AstraZeneca and FibroGen’s roxadustat NDA for CKD related anemia https://lifescivoice.com/fibrogen-and-astrazeneca-an-roxadustat-fda-rejects-nda-ckd-anaemia/ Life Sciences Voice | The leading resource for life sciences industry executives. Mon, 23 Aug 2021 19:49:42 +0000 hourly 1 https://wordpress.org/?v=6.8.1